BPOF & APGCS 2024

Published: 31 July 2024

Details:

Gene Solutions is proud to participate in the Biomarkers and Precision Oncology Forum (BPOF) and APGCS 2024 in Singapore. Our involvement highlights our dedication to advancing precision oncology. We will present our latest research and engage with global and regional experts to drive innovation in cancer care.

Our Research Associate, Ms. Van Anh, MSc., will be featured at the forum with an abstract titled: “Prognostic value of post-operative ctDNA in solid tumor cancers.” This presentation underscores our commitment to advancing precision oncology and highlights our role in the ongoing innovation in cancer care.

The Asia Pacific Gastroenterology Cancer Summit (APGCS) is a leading GI Cancer Care conference in the Asia-Pacific region. It includes symposiums, debates, lectures, panel discussions, and poster sessions. The 11th Edition in 2024 will feature world-renowned speakers discussing the latest in gastrointestinal cancer therapeutics.

Held on August 29, 2024, the 2nd Biomarkers and Precision Oncology Forum (BPOF) will focus on personalized cancer therapies, including Precision Oncology and Targeted Therapy for Breast, GI/GU, and Lung Cancers.

Asia-Pacific Gastroenterology Cancer Summit (APGCS) 2024, A leading GI Cancer Care conference in the Asia-Pacific region, APGCS will feature symposiums, debates, lectures, panel discussions, and poster sessions. Since 2013, APGCS has been a key platform for groundbreaking research and real-world case discussions in GI Cancer Care.

BPOF & APGCS 2024 is committed to maintaining a cutting-edge scientific program, offering attendees the opportunity to engage with pivotal discussions through keynote presentations by global thought leaders, the sharing of clinical practice expertise from regional luminaries, and the stimulation of interdisciplinary tumor boards.

Join us in Singapore for an exceptional opportunity to engage with leaders in oncology and drive forward the future of cancer care at BPOF & APGCS 2024.